Table 2 The associations between the SNP rs1516569 of GRM7 and schizophrenia.

From: Variants of GRM7 as risk factor and response to antipsychotic therapy in schizophrenia

Study

Chr

BP

SNP

A1

A2

OR

P

GWAS1 of CSCG19 (746 cases and 1599 controls)

3

7004873

rs1516569

C

G

1.06

0.66

GWAS2 of CSCG19 (1595 cases and 1447 controls)

3

7004873

rs1516569

C

G

1.11

0.12

PGC-Asian20 (22,778 cases and 35,362 controls)

3

7004873

rs1516569

C

G

0.97

0.72

PGC-Clozuk18 (40,675 cases and 64,643 controls)

3

7004873

rs1516569

C

G

0.95

7.63E-05

Meta-analysis 65,794 cases and 103,051 controls

3

7004873

rs1516569

C

G

0.85

3.47E-04

  1. GWAS1 and GWAS2 of CSCG were not included in PGC Asian project. Therefore, we performed a meta-analysis of four GWAS datasets.
  2. CHR chromosome, SNP single nucleotide polymorphism, BP base position, A1/A2 minor allele/major allele, OR odds ratio.